1. Gupta G, de Jesus Andreoli Pinto T, Chellappan DK, Mishra A, Malipeddi H, Dua K. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med. 2018;60(2):70-5. [
Link] [
DOI:10.23736/S0031-0808.18.03394-3]
2. Xin GLL, Khee YP, Ying TY, Chellian J, Gupta G, Kunnath AP, et al. Current status on immunological therapies for type 1 Diabetes mellitus. Curr Diab Rep. 2019;19(5);22. [
Link] [
DOI:10.1007/s11892-019-1144-3]
3. Miettinen ME, Smart MC, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Ylivinkka I, et al. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child. PloS One. 2017;12:e0184942. [
Link] [
DOI:10.1371/journal.pone.0184942]
4. Penna-Martinez M, Badenhoop K. Inherited variation in Vitamin D Genes and Type 1 Diabetes predisposition. Genes. 2017;8(4):125. [
Link] [
DOI:10.3390/genes8040125]
5. Nam HK, Rhie YJ, Lee YH. Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes. Pediatric Diabetes. 2019;20(6):750-8. [
Link] [
DOI:10.1111/pedi.12878]
6. Ahmed AE, Sakhr HM, Hassan MH, El-Amir MI, Ameen HH. Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy. Diabetes Metab Syndr Obes. 2019;12:703-16. [
Link] [
DOI:10.2147/DMSO.S201525]
7. Habibian N, Amoli MM, Abbasi F, Rabbani A, Alipour A, Sayarifard F, et al. Role of vitamin D and vitamin D receptor gene polymorphisms on residual beta cell function in children with type 1 diabetes mellitus. Pharmacol Rep. 2019;71(2):282-8. [
Link] [
DOI:10.1016/j.pharep.2018.12.012]
8. Rasoul MA, Haider MZ, Al-Mahdi M, Al-Kandari H, Dhaunsi GS. Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children. BMC Pediatrics. 2019;19(1):71. [
Link] [
DOI:10.1186/s12887-019-1448-0]
9. Ali R, Fawzy I, Mohsen I, Settin A. Evaluation of vitamin D receptor gene polymorphisms (Fok-I and Bsm-I) in T1DM Saudi children. J Clin Lab Anal. 2018;32(5):e22397. [
Link] [
DOI:10.1002/jcla.22397]
10. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;349:g7647. [
Link] [
DOI:10.1136/bmj.g7647]
11. Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism- a meta-analysis and systematic review. VASA. 2020;49(2):141-6. [
Link] [
DOI:10.1024/0301-1526/a000839]
12. Zhang W, Xu Y. Association between Vitamin D receptor gene polymorphism rs2228570 and allergic rhinitis. Pharmgenomics Pers Med. 2020;13:327-35. [
Link] [
DOI:10.2147/PGPM.S262402]
13. Al-Eisa AA, Haider MZ. Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome. Int J Nephrol Renovasc Dis. 2016;9:187-92. [
Link] [
DOI:10.2147/IJNRD.S111538]
14. Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, et al. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12(7):e0180512. [
Link] [
DOI:10.1371/journal.pone.0180512]
15. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: Pandemic?. Am J Clin Nutr. 2016;103(4):1033-44. [
Link] [
DOI:10.3945/ajcn.115.120873]
16. Sethuraman U, Zidan MA, Hanks L, Bagheri M, Ashraf A. Impact of vitamin D treatment on 25 hydroxy vitamin D levels and insulin homeostasis in obese African American adolescents in a randomized trial. J Clin Transl Endocrinol. 2018;12:13-9. [
Link] [
DOI:10.1016/j.jcte.2018.03.002]
17. Magge SN, Prasad D, Zemel BS, Kelly A. Vitamin D3 supplementation in obese, African-American, vitamin D deficient adolescents. J Clin Transl Endocrinol. 2018;12:1-7. [
Link] [
DOI:10.1016/j.jcte.2018.03.001]
18. Brar PC, Contreras M, Fan X, Visavachaipan N. Effect of one time high dose "stoss therapy" of vitamin D on glucose homeostasis in high risk obese adolescents. Arch Endocrinol Metab. 2018;62(2):193-200. [
Link] [
DOI:10.20945/2359-3997000000024]
19. Smith TJ, Tripkovic L, Hauger H, Damsgaard CT, Mølgaard C, Lanham-New SA, et al. Winter cholecalciferol supplementation at 51°N has no effect on markers of cardiometabolic risk in healthy adolescents aged 14-18 years. J Nutr. 2018;148(8):1269-75. [
Link] [
DOI:10.1093/jn/nxy079]
20. Hauger H, Mølgaard C, Mortensen C, Ritz C, Frøkiær H, Smith TJ, et al. Winter cholecalciferol supplementation at 55°n has no effect on markers of cardiometabolic risk in healthy children aged 4-8 years. J Nutr. 2018;148(8):1261-8. [
Link] [
DOI:10.1093/jn/nxy080]
21. Ferira AJ, Laing EM, Hausman DB, Hall DB, McCabe GP, Martin BR, et al. Vitamin D supplementation does not impact insulin resistance in black and white children. J Clin Endocrinol Metab. 2016;101(4):1710-8. [
Link] [
DOI:10.1210/jc.2015-3687]